PTC Therapeutics, Inc. P/S ratio

P/S ratio of PTCT for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.


Highlights and Quick Summary

Current P/S ratio of PTC Therapeutics, Inc. is 5.23 (as of December 31, 2021)
  • P/S ratio for the quarter ending June 30, 2022 was 4.62 (a -0.89% decrease compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -13.33%
  • Annual P/S ratio for 2021 was 5.23 (a -50.62% decrease from previous year)
  • Annual P/S ratio for 2020 was 10.58 (a 14.91% increase from previous year)
  • Annual P/S ratio for 2019 was 9.21 (a 52.53% increase from previous year)
Visit stockrow.com/PTCT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of PTC Therapeutics, Inc.

Most recent P/S ratioof PTCT including historical data for past 10 years.

Interactive Chart of P/S ratio of PTC Therapeutics, Inc.

PTC Therapeutics, Inc. P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 4.62 4.67
2021 5.23 5.34 6.31 7.72 5.23
2020 10.58 8.82 10.62 8.65 10.58
2019 9.21 6.43 9.05 8.1 9.21
2018 6.04 8.72 6.39 4.83 6.04
2017 3.52 6.09 5.92 3.74 3.52
2016 4.62 6.8 4.18 4.53 4.62
2015 29.63 24.68 56.53 85.59 29.63
2014 64.73 75.99 24.27 17.41 64.73
2013 6.27 13.83 1.43 0.0 6.27
2012 0.0 0.0 0.0 0.0 0.0
2011 0.0

Business Profile of PTC Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology